Assessment of Healthcare Professionals' Preparedness to Screen for and Manage Women Experiencing Intimate Partner Violence During the Perinatal Period
Condition(s) studied
Investigational drug(s) / intervention(s)
PREMIS Questionnaire: Participants, consisting of perinatal healthcare professionals (midwives, obstetricians, nurses, and related staff) at AP-HP, will complete the PREMIS (Physician Readiness to Manage Intimate Partner Violence Survey) self-administered questionnaire. The questionnaire evaluates their preparedness to screen for, identify, and manage women experiencing intimate partner violence during the perinatal period.
Study summary
AP-HP has recently opened five hospital-based care units dedicated to supporting women who are victims of violence. Referrals of women to these units rely mainly on healthcare professionals. Despite the recommendations of the French National Authority for Health (HAS), screening for Intimate Partner Violence (IPV) is not systematically performed.
Moreover, although women tend to disclose experiences of violence preferentially to healthcare professionals, these professionals report feeling insufficiently trained to address this issue.
In France, only one national survey assessing knowledge and screening capacities regarding domestic violence has been conducted, and it was limited to midwives. No study has evaluated screening practices and the ability to manage women experiencing IPV.
One questionnaire is available: the PREMIS questionnaire (Physician Readiness to Manage Intimate Partner Violence Survey). This self-administered questionnaire includes 67 items and was developed and validated in a population of healthcare professionals in the United States. It demonstrated good internal consistency, with a Cronbach's alpha coefficient greater than 0.65 for all validated subscales. Its external validity was also tested by comparing questionnaire responses with a field-based observational survey of professional practices, showing good correlation. Stability of responses over time (12 months) was also demonstrated. The questionnaire is able to discriminate between respondents who have received training and those who have not, with a positive correlation between knowledge acquired through experience and the number of hours of personal training. To our knowledge, it is the only validated tool to assess healthcare professionals' preparedness to screen for and manage intimate partner violence. Its French transcultural adaptation was scientifically validated in 2021.
Eligibility
Primary outcome measure(s)
- Conducting routine screening by healthcare professionals. — Day 1
Based on the responses to the questionnaires, determine the number of healthcare professionals at the APHP who screen pregnant women for domestic violence and the potential impact on this practice of having a specialized care unit for women who are victims of domestic violence.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Maison des femmes - Hôtel Dieu | Paris | Île-de-France Region |
More Assistance Publique - Hôpitaux de Paris trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07818096 on ClinicalTrials.gov ↗ ← All trials in France